Informed Consent and Diagnostic Disclosure

Receiving a neurodivergent diagnosis — or learning that one is being considered — is a significant clinical moment. For some clients, it's a relief. For others, it's destabilizing. The ethical obligations around this moment are substantial, and how you handle it can shape the client's relationship with their own neurology for years.

The Weight of a Diagnosis

A late ADHD or autism diagnosis often triggers a reevaluation of the client's entire life. The adult who learns at 38 that they're autistic may suddenly reinterpret decades of social difficulty, career struggles, and relationship patterns through a completely new lens. This can be liberating — "I'm not broken, my brain just works differently" — or it can surface grief and anger about years of misunderstanding and missed support.

Your role isn't to steer the client toward one reaction. It's to hold space for whatever comes up and to be transparent about the process. Informed consent around diagnostic assessment means the client understands what you're evaluating, why, what the possible outcomes are, and what a diagnosis would and wouldn't mean for their life and treatment.

Ethical Obligations in Assessment

If you're conducting a neurodivergent assessment, several ethical considerations apply.

Competence boundaries. Administering and interpreting diagnostic instruments requires specific training. If your training doesn't include standardized ADHD or autism assessment, your ethical obligation is to refer — not to informally diagnose based on clinical impression alone. An informal "I think you might have ADHD" without proper assessment can create confusion, false certainty, or delayed access to appropriate evaluation.

Cultural and demographic bias in instruments. Most diagnostic tools were normed on white, male, middle-class populations. Autism in women and girls often presents differently than the stereotypical profile. ADHD in Black and Latino clients is frequently misread as behavioral problems. Be transparent with clients about these limitations and factor them into your clinical reasoning.

Disclosure is a conversation, not a pronouncement. When sharing diagnostic results, approach it collaboratively. Ask what the client already suspects. Explore what the diagnosis means to them. Provide psychoeducation about what the diagnosis is and isn't. Connect them with community resources — peer groups, books, online communities — where they can hear from others with similar experiences.

After Disclosure

The session after a diagnosis is often more important than the disclosure session itself. Check in on how the client has been processing the information. Have they told anyone? What reactions did they get? What questions have come up?

Many clients go through a period of "rewriting" — looking back at their life through the new diagnostic lens. This is normal and often therapeutically productive, but it can also become consuming. Help the client balance reflection with forward movement: "Now that we have this information, what do you want to do with it?"

In Session

Before initiating any diagnostic assessment, have an explicit informed consent conversation. Document it. Explain what you'll be evaluating, what instruments you'll use, their known limitations, and what the possible outcomes mean for treatment. This conversation protects the client, strengthens the therapeutic alliance, and models the transparency that neurodivergent-affirming care requires.